Anderson PM - Search Results

1

Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy.

Anderson PM, Schroeder G, Skubitz KM. Anderson PM, et al. Cancer. 1998 Oct 1;83(7):1433-9. doi: 10.1002/(sici)1097-0142(19981001)83:7<1433::aid-cncr22>3.0.co;2-4. Cancer. 1998. PMID: 9762946 Clinical Trial.

2

Phase I study of CI-958 in children and adolescents with recurrent solid tumors.

Arndt CA, Krailo MD, Liu-Mares W, Anderson PM, Reaman GH. Arndt CA, et al. Among authors: anderson pm. Cancer. 2001 Mar 15;91(6):1166-9. doi: 10.1002/1097-0142(20010315)91:6<1166::aid-cncr1113>3.0.co;2-y. Cancer. 2001. PMID: 11267962 Clinical Trial.

3

Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial.

Skubitz KM, Anderson PM. Skubitz KM, et al. Among authors: anderson pm. Anticancer Drugs. 2000 Aug;11(7):555-63. doi: 10.1097/00001813-200008000-00006. Anticancer Drugs. 2000. PMID: 11036958 Clinical Trial.

4

Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.

Skubitz KM, Anderson PM. Skubitz KM, et al. Among authors: anderson pm. J Lab Clin Med. 1996 Feb;127(2):223-8. doi: 10.1016/s0022-2143(96)90082-7. J Lab Clin Med. 1996. PMID: 8636652 Clinical Trial.

5

Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation.

Anderson PM, Ramsay NK, Shu XO, Rydholm N, Rogosheske J, Nicklow R, Weisdorf DJ, Skubitz KM. Anderson PM, et al. Bone Marrow Transplant. 1998 Aug;22(4):339-44. doi: 10.1038/sj.bmt.1701317. Bone Marrow Transplant. 1998. PMID: 9722068 Clinical Trial.

6

Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent.

Saltzman DA, Heise CP, Hasz DE, Zebede M, Kelly SM, Curtiss R 3rd, Leonard AS, Anderson PM. Saltzman DA, et al. Among authors: anderson pm. Cancer Biother Radiopharm. 1996 Apr;11(2):145-53. doi: 10.1089/cbr.1996.11.145. Cancer Biother Radiopharm. 1996. PMID: 10851531

7

Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2: a novel anti-tumor agent.

Saltzman DA, Katsanis E, Heise CP, Hasz DE, Kelly SM, Curtiss R 3rd, Leonard AS, Anderson PM. Saltzman DA, et al. Among authors: anderson pm. Cancer Biother Radiopharm. 1997 Feb;12(1):37-45. doi: 10.1089/cbr.1997.12.37. Cancer Biother Radiopharm. 1997. PMID: 10851445

8

In vitro and in vivo cytotoxicity of an anti-osteosarcoma immunotoxin containing pokeweed antiviral protein.

Anderson PM, Meyers DE, Hasz DE, Covalcuic K, Saltzman D, Khanna C, Uckun FM. Anderson PM, et al. Cancer Res. 1995 Mar 15;55(6):1321-7. Cancer Res. 1995. PMID: 7882330

9

Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Preliminary results in children with acute lymphocytic leukemia and neuroblastoma.

Anderson PM, Bach FH, Ochoa AC. Anderson PM, et al. Cancer Immunol Immunother. 1988;27(1):82-8. doi: 10.1007/BF00205763. Cancer Immunol Immunother. 1988. PMID: 3260824

10

Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.

Ochoa AC, Hasz DE, Rezonzew R, Anderson PM, Bach FH. Ochoa AC, et al. Among authors: anderson pm. Cancer Res. 1989 Feb 15;49(4):963-8. Cancer Res. 1989. PMID: 2521457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results